Staphylococcus aureus DSM 25630 is a mesophilic human pathogen that has multiple antibiotic resistances.
antibiotic resistance mesophilic human pathogen| @ref 20215 |
Last LPSN update
2025-12-16 09:50:22 |
| Domain Bacillati |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 18075 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 18075 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 18075 | positive | growth | 37 | mesophilic |
| Test 1 | Test 2 | Test 3 | |
|---|---|---|---|
| @ref | 18075 | 18075 | 18075 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar |
| Incubation temperature | 37 | 37 | 37 |
| Incubation time | 1 | ||
| Oxygen condition | aerob | aerob | aerob |
| Manual_annotation | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Penicillin G | 6 | 6 | 6 |
| Oxacillin | 0 | 0 | 0 |
| Ampicillin | 6-8 | 8 | 8 |
| Ticarcillin | 8 | 10 | 10 |
| Mezlocillin | 8 | 8 | 8 |
| Cefalotin | 8 | 6 | 6 |
| Cefazolin | 0 | 0 | 0 |
| Cefotaxime | 0 | 0 | 0 |
| Aztreonam | 0 | 0 | 0 |
| Imipenem | 0 | 6 | 6 |
| Tetracycline | 16-18 | 12-14 | 12-14 |
| Chloramphenicol | 30 | 30 | 30 |
| Gentamycin | 10-12 | 10 | 10 |
| Amikacin | 20-22 | 22 | 22 |
| Vancomycin | 22 | 20 | 20 |
| Erythromycin | 0 | 0 | 0 |
| Lincomycin | 0 | 0 | 0 |
| Ofloxacin | 0 | 0 | 0 |
| Norfloxacin | 0 | 0 | 0 |
| Colistin | 0 | 0 | 0 |
| Pipemidic acid | 0 | 0 | 0 |
| Nitrofurantoin | 28 | 24-26 | 24-26 |
| Bacitracin | 18 | 14 | 14 |
| Polymyxin b | 8 | 6 | 6 |
| Kanamycin | 8 | 8 | 8 |
| Neomycin | 14-16 | 16 | 16 |
| Doxycycline | 20 | 20 | 20 |
| Ceftriaxone | 0 | 0 | 0 |
| Clindamycin | 0 | 0 | 0 |
| Fosfomycin | 22-24 | 20 | 20 |
| Moxifloxacin | 0 | 0 | 0 |
| Linezolid | 34 | 40 | 40 |
| Nystatin | 0 | 0 | 0 |
| Quinupristin/dalfopristin | 28 | 28-30 | 28-30 |
| Teicoplanin | 18 | 18 | 18 |
| Piperacillin/tazobactam | 8 | 8 | 8 |
| 18075 | ObservationMRSA |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | + | fermentation | from API ID32STA |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 59640 ChEBI | N-acetylglucosamine | + | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | + | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | + | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 18075 | catalase | + | 1.11.1.6 | |
| 18075 | cytochrome-c oxidase | - | 1.9.3.1 | |
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| @ref | URE | ADH (Arg) | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | Reduction of nitrateNIT | Acetoin production (Voges Proskauer test)VP | beta GAL | L-arginine arylamidaseArgA | PAL | Pyrrolidonyl arylamidasePyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18075 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | + | - | + | + | + | - | - | |
| 18075 | +/- | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | + | + | + | + | - | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| In Vitro Study to Assess Effective Cleaning Techniques for Removing Staphylococcus aureus from Menstrual Cups. | Wunsch N, Green SJ, Adam S, Hampton J, Phillips-Howard PA, Mehta SD. | Int J Environ Res Public Health | 10.3390/ijerph19031450 | 2022 | | |
| Pathogenicity | Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories. | Hong SK, Choi SJ, Shin S, Lee W, Pinto N, Shin N, Lee K, Hong SG, Kim YA, Lee H, Kim H, Song W, Lee SH, Yong D, Lee K, Chong Y. | Ann Lab Med | 10.3343/alm.2015.35.6.635 | 2015 | |
| Propionate Ameliorates Staphylococcus aureus Skin Infection by Attenuating Bacterial Growth. | Jeong S, Kim HY, Kim AR, Yun CH, Han SH. | Front Microbiol | 10.3389/fmicb.2019.01363 | 2019 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive14499.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License